当前位置:首页 - 行情中心 - 九强生物(300406) - 财务分析

九强生物

(300406)

  

流通市值:69.00亿  总市值:95.66亿
流通股本:4.24亿   总股本:5.88亿

九强生物(300406)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润5.31亿元,每股收益0.92元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益413279.99万元,未分配利润278952.26万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产557496.52万元,负债144216.52万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入1,658,931,975.391,237,396,355.82821,722,324.81393,894,885.38
营业总成本1,056,135,883.84793,399,425.93518,454,199.71252,157,863.84
营业利润624,050,562.29443,677,728.79302,644,933.66144,380,239.45
利润总额620,689,059.36441,532,898.97300,574,955.91142,407,950.93
净利润531,162,206372,402,279249,587,292.26120,219,484.04
其他综合收益280,702.14-163,841.94110,421.3637,868.49
综合收益总额531,442,908.14372,238,437.06249,697,713.62120,257,352.53
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计2,580,998,523.172,597,126,673.952,604,421,562.752,743,372,108.32
非流动资产合计2,993,966,639.182,860,040,238.912,694,255,324.262,534,729,999.44
资产总计5,574,965,162.355,457,166,912.865,298,676,887.015,278,102,107.76
流动负债合计278,129,608.55287,588,481.79251,359,490.96247,582,649.08
非流动负债合计1,164,035,605.411,205,030,145.961,197,546,091.231,188,221,799.98
负债合计1,442,165,213.961,492,618,627.751,448,905,582.191,435,804,449.06
归属于母公司股东权益合计4,138,374,136.023,970,743,202.73,855,551,704.933,847,752,663.85
股东权益合计4,132,799,948.393,964,548,285.113,849,771,304.823,842,297,658.7
负债和股东权益合计5,574,965,162.355,457,166,912.865,298,676,887.015,278,102,107.76
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计1,891,598,392.211,355,254,133.75897,787,083.25413,326,787.63
经营活动现金流出小计1,277,586,462.95951,980,056.32675,320,318.53395,775,987.11
经营活动产生的现金流量净额614,011,929.26403,274,077.43222,466,764.7217,550,800.52
投资活动现金流入小计672,307,553.42274,149,272.89324,878,672.89314,730,786.14
投资活动现金流出小计690,927,208.69236,089,077.7183,127,236.4739,384,851.07
投资活动产生的现金流量净额-18,619,655.2738,060,195.18241,751,436.42275,345,935.07
筹资活动现金流入小计29,258,866.2726,176,061.3622,823,499.6522,285,066.76
筹资活动现金流出小计205,739,197.57184,779,404.88157,541,550.915,153,782.09
筹资活动产生的现金流量净额-176,480,331.3-158,603,343.52-134,718,051.2617,131,284.67
汇率变动对现金及现金等价物的影响515,978.68197,327.3528,579.05-284,324.29
现金及现金等价物净增加额419,427,921.37282,928,256.44329,528,728.93309,743,695.97
期末现金及现金等价物余额1,131,058,401.84994,558,736.911,041,159,209.41,021,374,176.44
最新报告期:2025-04-02
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
光大证券王明瑞,黎一江0.911.061.262025-04-02
中泰证券于佳喜,祝嘉琦,谢木青0.941.091.292025-03-31
TOP↑